Skip to main content
GrowAG Logo
Opportunities

The Bioeconomy Science Institute: Bioactive molecules as antimicrobial products - research partnership

Opportunity for

  • Ag chem companies interested in supporting early R&D of bio control crop protection products
  • Animal health companies interested in supporting early R&D of antimicrobial products for livestock
  • Industry partners, funding bodies, RDCs interested in collaboration projects with The New Zealand Bioeconomy Science Institute .

Opportunity description

Industry challenge:

The Bioeconomy Science Institute is currently conducting trial validation using bioactive compounds to reduce incidences of bovine mastitis and facial eczema in animals. These problems can significantly affect animal productivity and therefore export revenue.

Parallel to this we have also observed in laboratory trials that some other bioactive molecules reduce other fungal and bacterial pathogens, that are threat to many crops. Due to the broad-spectrum efficacy, we plan to utilise these biomolecules as biopesticides and provide sustainable solutions or products for agriculture.

The industry challenges are to find sustainable and natural solutions to solve animal health and crop diseases, while showing efficacy.

Current opportunity:

Since the bioactive molecules' activity seems to be quiet broad, we are wanting to identify opportunities where our product could solve other actual industry problems.

We would like to have the opportunity to get in front of relevant Australian companies to discuss our solution and be able to validate its need. Therefore, having those connections or industry introductions would be very helpful and crucial.

Opportunity background:

We have validated laboratory results confirming the activity of the bioactive molecules against a fungus causing facial eczema in animals and other fungi threat to important crops. We have also shown high efficacy of these biomolecules against a range of Gram positive and Gram negative bacteria, affecting our food system. Results are positive at this stage with maximum efficacy. We have identified a range of biomolecules that can be used for developing biopesticides/antimicrobials.

Share